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Abstract
Mucosal-Associated Invariant T (MAIT) cells, present in high frequency in airway and other
mucosal tissues, have Th1 effector capacity positioning them to play a critical role in the
early immune response to intracellular pathogens, includingMycobacterium tuberculosis
(Mtb). MR1 is a highly conserved Class I-like molecule that presents vitamin B metabolites
to MAIT cells. The mechanisms for loading these ubiquitous small molecules are likely to be
tightly regulated to prevent inappropriate MAIT cell activation. To define the intracellular
localization of MR1, we analyzed the distribution of an MR1-GFP fusion protein in antigen
presenting cells. We found that MR1 localized to endosomes and was translocated to the
cell surface upon addition of 6-formyl pterin (6-FP). To understand the mechanisms by
which MR1 antigens are presented, we used a lentiviral shRNA screen to identify trafficking
molecules that are required for the presentation of Mtb antigen to HLA-diverse T cells. We
identified Stx18, VAMP4, and Rab6 as trafficking molecules regulating MR1-dependent
MAIT cell recognition of Mtb-infected cells. Stx18 but not VAMP4 or Rab6 knockdown also
resulted in decreased 6-FP-dependent surface translocation of MR1 suggesting distinct
pathways for loading of exogenous ligands and intracellular mycobacterially-derived
ligands. We postulate that endosome-mediated trafficking of MR1 allows for selective sam-
pling of the intracellular environment.
Author Summary
Tuberculosis, caused by the bacteriumMycobacterium tuberculosis (Mtb), remains a global
health concern, with an estimated 9 million new cases and 1.5 million deaths each year.
Mucosal-associated invariant T (MAIT) cells were recently identified as a non-classical
CD8+ T cell subset that responds to intracellular infection with Mtb and other microbes.
MAIT cells recognize vitamin B metabolites presented on the Class I like molecule, MR1.
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MAIT cell recognition is likely to be tightly regulated to allow for the detection of intracel-
lular infection while avoiding tissue damage. In this manuscript, we have characterized the
intracellular localization and trafficking of MR1 at basal conditions and in the presence of
a known ligand. Furthermore, we have investigated the role of intracellular trafficking in
MR1 presentation of ligands to MAIT cells in the context of intracellular infection with
Mtb. We show that, in contrast to other Class I molecules, MR1 resides in endosomal com-
partments and translocates to the cell surface in the presence of ligand. We went on to
identify trafficking molecules that are required for the presentation of Mtb antigen to
HLA-diverse T cells, and found at least seven trafficking molecules that are specifically
involved in regulating MR1-dependent recognition of human MAIT cells. Among these,
we show that Syntaxin 18 (Stx18), vesicle-associated membrane protein 4 (VAMP4), and
Rab6 play distinct roles in the trafficking of MR1+ endosomal compartments. Further-
more, our results demonstrate that exogenously added ligands and those derived during
intracellular infection are presented through different mechanisms. Our results provide a
conceptual framework underlying the regulation of MAIT cell activation.
Introduction
Mucosal-Associated Invariant T (MAIT) cells are a class of CD8+ T cells that are unique in
their use of a semi-invariant TCR, restriction by the highly conserved major histocompatibility
complex, class I-related protein 1 (MR1), and their recognition of small molecule metabolites.
In support of a role for these cells in host-defense to mucosal infection, human MAIT cells are
present in high numbers in mucosal tissues and blood [1, 2] and secrete pro-inflammatory
molecules including TNFα and IFN-γ [3, 4]. MAIT cells have the capacity to respond to intra-
cellular pathogens such asMycobacterium tuberculosis (Mtb) [3] and Francisella tularensis [5]
and animal models demonstrate a requirement for MR1, and by inference, MAIT cells in early
control of certain pathogens [5–7]. Although MR1 is ubiquitously expressed in all mammalian
tissues examined, surface expression is very low or undetectable in both phagocytic profes-
sional antigen presenting cells and non-hematopoetic cells [8, 9]. Previous work demonstrated
that MR1 surface expression in mouse cells overexpressing MR1 requires both the MHC-II
chaperone, invariant chain (Ii), and trafficking through late endosomal compartments [10].
This is in contrast to the constitutive surface expression of other Class I molecules, and may be
key to understanding the regulation of MR1-restricted MAIT cell activation.
The McCluskey and Rossjohn groups have identified Vitamin B metabolites as ligands that
bind and stabilize MR1 [11, 12]. With regard to MAIT cell activation, pterins, which are
derived from folic acid (6-formylpterin (6-FP and ac-6-FP)), are antagonistic, while the bacteri-
ally-derived riboflavin metabolites known as lumazines (RL-6,7-diMe, RL-6-Me-7-OH, and
rRL-6-CH2OH) are agonists [11]. More recently an additional class of ligands, pyrimidines
(5-OE-RU, 5-OP-RU), were identified as potent activators of MAIT cells. These pyrimidines
are generated in a chemical reaction between bacterially-derived riboflavin precursor molecules
and small metabolites derived from either the host or pathogen [13]. Currently, little is known
about the intracellular localization of MR1, how and where MR1 is loaded with these ligands,
or the mechanism for MR1 translocation to the cell surface. The ubiquitous expression of MR1
in many tissues, the high frequency of MAIT cells in both the blood and mucosal tissues, and
the prevalence of potentially activating ligands likely requires that MR1 loading and trafficking
be tightly regulated to prevent indiscriminant MAIT cell activation. Although Ii was proposed
as a required chaperone for MR1 [10], we have demonstrated that airway epithelial cells (AEC)
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are highly efficient at presenting antigen to MAIT cells [14] even though they do not express
MHC class II or Ii. The ability of AEC to efficiently present mycobacterial antigens and their
proximity to MAIT cells in the lung suggests they may play an important role in early recogni-
tion of exposure to Mtb or other pathogens. In this study, we sought to define intracellular traf-
ficking pathways necessary for the presentation of Mtb-derived MR1 ligands by AEC to
human MAIT cells.
Results
MR1 localizes to vesicular compartments with late endosome and
lysosome markers
To determine the basal intracellular localization of MR1 in AEC, we expressed MR1 fused to
green fluorescent protein (GFP) in the BEAS-2B airway epithelial cell line and primary normal
human bronchial epithelial cells (NHBE). To establish that the MR1-GFP protein was func-
tional, cells expressing MR1-GFP were infected with Mtb orMycobacterium smegmatis and
used as antigen presenting cells (APC) in an IFNγ ELISPOT assay. The response of MR1-res-
tricted T cells was increased with MR1-GFP over-expression with no impact on IFNγ produc-
tion by HLA-E or HLA-B45 restricted T cells (Fig 1A). We next sought to define the
subcellular localization of MR1-GFP using high-resolution deconvolution microscopy. As
expected, in both BEAS-2B and NHBE cells, the majority of MR1 observed was intracellular,
with expression in an endoplasmic reticulum (ER)-like subcellular compartment as well as
endosomal compartments (EC) (Fig 1B, S1 Movie). This was in contrast to MHC-I, which was
largely localized to the plasma membrane (Fig 1B). Staining with antibodies against the
ER-Golgi intermediate compartment (ERGIC-53) the trans-Golgi network (TGN-46) demon-
strated that a proportion of the MR1-GFP localized to these compartments (Fig 1C), while sub-
sets of the MR1-GFP+ EC co-localized with markers that define late endosomes or lysosomes
(Rab7, Lamp1) but not early endosomes (Rab5) (Fig 1D, S2 Movie). The majority of the
MR1-GFP+ EC also co-localized with β-2-microglobulin (β-2M) (Fig 1D). These MR1+ β-2M+
EC have a similar phenotype to the Mtb compartment in AEC [14] and may represent a pre-
synthesized pool of MR1 that could be loaded in the context of intracellular infection.
Incubation with 6-FP results in translocation of MR1 to the cell surface
Recent reports indicate that incubation of cells with acetyl-6-FP results in cell surface stabiliza-
tion of MR1 [12]. To define the impact of exogenously added ligand on the intracellular locali-
zation of MR1 in BEAS-2B and primary NHBE cells, MR1-GFP expressing cells were
incubated with 6-FP. As expected, incubation with 6-FP resulted in translocation of MR1-GFP
to the cell surface in both BEAS-2B and NHBE cells, detected by surface staining with the α-
MR1 26.5 antibody (red) (Fig 2A), which recognizes folded MR1 [13, 15]. Flow cytometry con-
firmed 6-FP dependent cell-surface translocation in cells expressing MR1-GFP and native
MR1 (Fig 2B). Inhibiting ER-Golgi transport with brefeldin A (BFA) dramatically decreased
the 6-FP-dependent cell surface stabilization of MR1 (Fig 2B), indicating that the dominant
processing and presentation pathway for 6-FP requires ER-Golgi transport.
The 6-FP-dependent translocation of MR1 to the cell surface was accompanied by a
decrease in the number of MR1-GFP+ EC in BEAS-2B and primary NHBE cells (Fig 2C) and
MR1-GFP+ EC were further depleted by cycloheximide (CHX) treatment (Fig 2C). When we
analyzed the co-localization of β-2M with the MR1-GFP+ EC remaining following treatment
with 6-FP, we found that the percentage of MR1-GFP+ β-2M+ EC decreased (Fig 2D). Together
MR1 Trafficking and MAIT Cell Recognition
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these data indicate that the MRI+ β-2M+ EC are a source of intracellular MR1 molecules avail-
able for ligand-binding and translocation to the cell surface.
Identification of trafficking molecules in AEC required for presentation of
Mtb ligands on MR1
The identification of vitamin B metabolites as MR1 ligands [11], the observation that process-
ing and presentation is both TAP and proteasome independent [3, 10], and apparent require-
ment for ligand in the cell surface stabilization of intracellular MR1 suggest a unique
mechanism for MR1 antigen processing and presentation. To define this mechanism in the
context of intracellular infection with a pathogen, we designed a screen to identify trafficking
proteins that are essential for MR1-dependent MAIT cell activation in the setting of intracellu-
lar infection with Mtb (S1 Fig). Here, shRNA knockdown of trafficking molecules in BEAS-2B
cells expressing native MR1 was performed, and T-cell dependent release of IFN-γ was
Fig 1. Expression of MR1 in epithelial cells. a) BEAS-2B cells were transfected with pCI:MR1-GFP, infected with Mtb orM. smegmatis and used as
antigen presenting cells in an IFNγ ELISPOT assay with IFNγ production by MR1-, HLA-E, and HLA-B45-restricted T cell clones as a readout for antigen
presentation. Error bars represent technical replicates. Data are representative of three independent experiments, *p = 0.03; **p<0.01. b) BEAS-2B or
primary NHBE cells were transfected with pCI:MR1-GFP and imaged live after 48 hours. For MHC-I visualization, BEAS-2B cells were fixed and stained with
antibody against MHC-I (W6/32). Images are representative of at least three independent experiments. c) BEAS-2B cells were transfected with pCI:
MR1-GFP then fixed and stained with α-ERGIC-53 or α-TGN46, and imaged. Images are representative of three independent experiments. d) BEAS-2B cells
were transfected with pCI:MR1-GFP then incubated with the CellLights reagents for late endosomes (Rab7), lysosomes (Lamp1), or early endosomes
(Rab5) for 48 hours, then imaged live. For β2M, MR1-GFP expressing cells were fixed then stained with α-β2M and imaged. Endosomal compartments were
identified and quantified as described in the Materials and Methods. Shown are representative images and the mean and standard deviation of the percent of
MR1-GFP+ EC co-localizing with the indicated marker from three independent experiments. *p<0.01, compared to Rab5 co-localization.
doi:10.1371/journal.ppat.1005524.g001
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measured following Mtb infection. To identify MR1-specific mechanisms, human Mtb-reactive
CD8+ T cell clones of known specificity (MR1 (D426 B1), HLA-E (D160 1–23), and HLA-B45
(D466 D6)) were tested in parallel with the same Mtb-infected APC. Candidate proteins were
identified by the selection criteria described in the Materials and Methods. Briefly, to reduce
the impact of non-specific shRNA targeting, genes where at least two independent shRNAs
resulted in reduced T cell recognition were considered candidates for subsequent siRNA vali-
dation. Based on these criteria, we identified candidate genes that fell into three categories with
regard to recognition by MAIT cells: 1) Genes where silencing did not result in reduced recog-
nition by any of the T cell clones; 2) Genes where silencing resulted in reduced recognition by
all of the T cell clones; and 3) Genes where silencing resulted in reduced recognition specifically
by MAIT cells. Examples are shown in Fig 3A, where silencing of Rab2b with multiple shRNAs
in BEAS-2B cells did not inhibit Mtb-dependent IFN-γ release by any of the T cell clones
tested, while silencing of Rab7L1 by multiple shRNAs inhibited responses by all T cell clones
tested, including MAIT cells. In contrast, silencing of Stx18 with shRNA selectively inhibited
only the response of the MAIT cell clone, D426B1, according to the selection criteria (Fig 3A).
In total, we identified 27 candidate genes where shRNA knockdown specifically resulted in
reduced MAIT cell recognition of Mtb-infected BEAS-2B cells.
Fig 2. Cell surface translocation of MR1 in the presence of ligand. a) BEAS-2B or primary NHBE cells were transfected with pCI:MR1-GFP and
incubated for 30 hours. Transfected cells were then incubated with 6-FP for 18 hours. For imaging, cells were fixed and surface stained with α-MR1 (26.5),
then imaged. In NHBE cells, MR1 surface staining (red) in MR1-GFP-expressing cells (green) is denoted by the arrows in the enlarged insets. Images shown
are representative of at least three independent experiments. b) BEAS-2B or NHBE cells were treated as described in a). Following 6-FP treatment cells
were harvested and surface stained on ice with α-MR1 (26.5). After staining, cells were fixed and analyzed by flow cytometry. Data shown are representative
of at least three independent experiments. Where indicated, cells were treated with 100ng/ml brefeldin A (BFA) for 2 hours prior to 6-FP addition. Shown is a
representative histogram demonstrating BFA blockade of 6-FP-dependent surface stabilization and the geometric mean and SEM of from three independent
experiments. c) BEAS-2B or NHBE cells were transfected with pCI:MR1-GFP and treated with 6-FP as described above. Where indicated, cells were treated
with10ug/ml cycloheximide (CHX) for 2 hours prior to 6-FP addition. Cells were fixed, and where indicated, stained with α-β2M, and imaged. Shown are
results from one of at least three independent experiments. The Mann-Whitney test was used to determine the statistical significance of CHX treatment. For
all other statistical comparisons, a Student’s t-test was used, *p<0.01. d) MR1-GFP+ β2M+ EC were identified and quantified as described in the Materials
and Methods. Each dot represents the number of endosomes in one cell for any of the conditions. Shown are results from one of at least three independent
experiments, *p<0.01.
doi:10.1371/journal.ppat.1005524.g002
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The ER-associated SNARE Stx18, and the endosome-associated
trafficking molecules VAMP4 and Rab6 are critical for MR1-dependent
MAIT cell activation in the context of Mtb infection
To date, we have evaluated ten of the 27 MAIT cell-specific candidates using siRNA knock-
down. Gene knockdown was confirmed using RT-PCR, and T cell-dependent release of IFN-γ
was responses were evaluated by ELISPOT assay. Silencing of eight of the ten candidates tested
by siRNA resulted in reduced response by the MAIT cell clone, seven of which were confirmed
to specifically impact only the MAIT cell clone. All candidates evaluated are listed in Table 1
and representative results are illustrated in Fig 3B. Here, Mtb-infected APC silenced with Stx18
siRNA had a substantially reduced ability to activate the MR1-restricted clone, with no effect
Fig 3. Identification of trafficking molecules involved in presentation of Mtb ligands on MR1. a) A lentiviral shRNA library of trafficking molecules was
screened by IFNγ ELISPOT assay with MR1, HLA-E, and HLA-B45 restricted T cell clones as described. Each bar represents separate shRNA wells and
each well was analyzed individually in relation to the mean and characterized as a hit if it was at least 25% below the mean. The mean was normalized to
100% and is represented by red line. Results from shRNA knockdown of Rab2b, Rab7L1, or Stx18 from three independent experiments are shown. Stars
indicate gene specific shRNA wells that met the candidate selection criteria. Candidates were selected if at least 2 of 5 independent shRNAs resulted in
reduced T cell response. b) BEAS-2B cells were treated with missense or Stx18 siRNA, infected with Mtb (MOI:5), and used as APC in an IFNγ ELISPOT
assay with 1x104 MR1, HLA-E, or HLA-B45 restricted T cells clones per well. Shown are the results using 5 x 103 APC that have been normalized to the
response to the Missense siRNA treated cells (100%). **p<0.01. Error bars represent the mean and SEM from four independent experiments. qRT-PCR
was performed on cDNA synthesized frommRNA isolated frommissense or Stx18 siRNA silenced BEAS-2B cells that were uninfected or infected with Mtb
(MOI:5). Error bars represent the mean and SEM for three independent experiments. Mtb colony forming units (CFU) from 1x105 infected cells were
determined by lysing and plating serial dilutions on 7H10 agar plates. Error bars represent the mean and SEM from 3 independent experiments. c) NHBE
cells were treated with missense or Stx18 siRNA and infected with Mtb (MOI:10). IFNγ ELISPOT and qRT-PCR analyses were performed as described for
BEAS-2B cells. Error bars represent the mean and SEM from two independent experiments. d) BEAS-2B cells were treated with missense, VAMP4, or Rab6
siRNA and infected with Mtb (MOI:5). IFNγ ELISPOT and qRT-PCR analyses were performed as described above. Error bars represent the mean and SEM
from at least three independent experiments, *p<0.01 compared to missense. e) BEAS-2B cells were treated with missense, Sec22b, BNIP1, or Use1 siRNA
and infected with Mtb (MOI:5). IFNγ ELISPOT and qRT-PCR analyses were performed as described above. Error bars represent the mean and SEM from at
least two independent experiments, *p<0.01 compared to missense.
doi:10.1371/journal.ppat.1005524.g003
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on activation of the HLA-E and HLA-B45-restricted clones, validating the results of the
shRNA screen. Furthermore, infection and intracellular viability of Mtb were not affected by
Stx18 silencing as demonstrated by quantitative culture of intracellular Mtb (Fig 3B). Similarly,
Stx18 silencing in Mtb-infected NHBE cells resulted in diminished MR1-dependent recogni-
tion of infection with Mtb (Fig 3C). Together, these data suggest that Stx18 is involved in a
mechanism that selectively impacts MR1-dependent antigen processing and/or presentation of
Mtb antigen by AEC. Because MR1 was observed in intracellular compartments in the endoso-
mal pathway, we also focused on two endosome-associated trafficking proteins, the R-SNARE
vesicle-associated membrane protein 4 (VAMP4) and Rab6, a small GTPase protein. Similar to
what was observed for Stx18, following VAMP4 or Rab6 silencing with siRNA, there was
diminished ability of Mtb-infected APC to activate MR1-restricted T cells (Fig 3D).
Stx18-dependent Golgi-ER retrograde transport is not required for MR1
processing and presentation of Mtb ligands
Stx18 is an ER-localized soluble NSF attachment protein receptor (SNARE) protein of the Qa-
SNARE family best known as a member of a SNARE complex regulating Golgi-ER retrograde
transport consisting of Stx18, BNIP1, Use1 (also called p31, D12, or MDS032), and Sec22b
[16]. Because Sec22b was also validated from the shRNA screen as an MR1-specific candidate,
we analyzed the role of this SNARE complex in Mtb antigen presentation to MAIT cells.
SNAREs known to partner with Stx18 were silenced by siRNA and tested for their ability to
activate MAIT cells. As expected, knockdown of Sec22b resulted in a similar reduction in
MAIT cell activation as was observed for Stx18. Knockdown of BNIP1 also resulted in a reduc-
tion in MAIT cell activation, however knockdown of Use1 did not have any impact (Fig 3E).
The SNAREs in this complex can also play a role in ER-mediated phagocytosis through inter-
actions with plasma membrane SNAREs [17] as well as post-Golgi trafficking pathways [18].
In fact, Stx18 has unusual properties for a Qa-SNARE, as it has a SNARE motif that is longer
than conventional SNAREs [19] and undergoes a different mechanism of SNARE complex
assembly compared to other ER SNAREs [20] that may allow it to function independently of
this complex. These data suggest MR1 processing and presentation may require a
Table 1. MR1 candidates evaluated using siRNA gene knockdown.
Gene Name Number of shRNA hits Validated by siRNA
Bet1 2 No
Rab3a 2 Yes
Rab3c 2 Yesa,b
Rab3GAP2 2 Yes
Rab6 3 Yesb
Rab34 2 Yes
Sec22b 3 Yesb
Stx18 3 Yesb
Vamp4 3 Yesc
Ykt6 2 No
a siRNA knockdown resulted in a similar functional effect (measured by ELISPOT assay) as observed
using shRNA, however we were unable to clearly show gene expression in BEAS-2B cells by qRT-PCR
b Tested with multiple independent siRNAs
c siRNA knockdown had a variable impact on response of the HLA-E-restricted T cell clone
doi:10.1371/journal.ppat.1005524.t001
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Stx18-mediated trafficking pathway distinct from the previously characterized Golgi-ER retro-
grade transport pathway.
Mtb-derived ligands are loaded on MR1 using a pathway distinct from
6-FP
To understand the mechanism by which these trafficking molecules regulate processing and
presentation of Mtb antigens on MR1, we looked for alteration in MR1 localization following
siRNA treatment. In HeLa cells, knockdown of Stx18 has been reported to affect the ER,
ER-Golgi intermediate compartment (ERGIC), and Golgi including disruption of the Golgi
stacks and ER exit sites and disorganization of ER membranes [21]. Knockdown of VAMP4 in
HeLa cells also results in dispersion of the Golgi [22] whereas knockdown of Rab6 does not dis-
perse the Golgi structure, but makes it more compact [23]. To confirm these observations,
Stx18, VAMP4, and Rab6 were silenced in BEAS-2B cells. Knockdown of Stx18 and VAMP4
resulted in the dispersion of the Golgi, while the structure of the Golgi in Rab6 silenced cells
was more compact (Figs 4A and S2). In the context of MR1-GFP expression, knockdown of
Stx18, VAMP4, and Rab6 resulted in an increase in the number of MR1-GFP+ EC (Fig 4B) and
in the amount of MR1 in those compartments, as measured by the mean intensity of GFP per
EC (Fig 4B).
The functional defect observed by ELISPOT and the increase in MR1-GFP+ EC led us to
hypothesize that silencing of these genes could result in diminished cell surface expression of
MR1 in the presence of a ligand. Knockdown of Stx18, VAMP4, and Rab6 did not alter basal
cell surface expression of MR1 in cells expressing endogenous MR1 or over-expressing
MR1-GFP (Fig 5A). However, Stx18 was required for ligand-dependent translocation of MR1
to the cell surface as Stx18 knockdown resulted in reduced translocation of MR1 to the cell sur-
face after incubation with 6-FP (Fig 5A). Knockdown of VAMP4 or Rab6 had no impact on
translocation of MR1 to the surface with 6-FP incubation (Fig 5A). Stx18, VAMP4, and Rab6
silencing all resulted in similar reduction in MR1-restricted T cell response to Mtb-infected
cells. The discordant results with 6-FP dependent MR1 surface stabilization in Stx18- and
VAMP4- or Rab6-silenced cells support a model in which the processing and presentation
pathways for exogenously added 6-FP and intracellular bacteria are distinct. Consistent with
this model, we observed colocalization of Stx18 with MR1 in the ER, while VAMP4 colocalized
with MR1 in EC (Fig 5B).
To further distinguish exogenously delivered versus intracellular antigen, we analyzed the
impact of pre-treatment with 6-FP, a MAIT cell antagonist, on the ability of MAIT cells to
respond to exogenous or endogenous antigen in the context of native MR1. Incubation of APC
withM. smegmatis supernatant resulted in MAIT cell activation, which could be abrogated by
pre-incubation of the APCs with 6-FP (Fig 5C). In contrast, in cells infected with Mtb, pre-
incubation with 6-FP did not significantly reduce MAIT cell activation (Fig 5C). These data
suggest that for processing and presentation of intracellular Mtb-derived antigen, there is an
endosomal pool of MR1 that is distinct from the pool preferentially loaded with 6-FP.
Discussion
MAIT cells are a unique class of MR1-restricted T cells capable of recognizing small molecule
vitamin B metabolites. There is a growing appreciation for the importance of these cells in the
mucosal response to intracellular microbial infection. At present, little is known about the
mechanisms by which this novel class of antigens are processed and presented. As we have
demonstrated previously, MAIT cells recognize Mtb-infected dendritic and epithelial cells and
are present in high numbers in lung tissues [3, 14, 24]. We postulate that the circumstances by
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which MAIT cells become activated is tightly regulated to allow for the recognition of intracel-
lular infection while avoiding tissue damage. Here we have demonstrated that MR1 is primarily
localized to an endosomal compartment, and have identified trafficking molecules responsible
for presentation of Mtb antigens on MR1. These results provide a framework with which to
understand the mechanisms regulating activation of MAIT cells.
While we and others have shown that exogenous ligands such as the short-lived ribitylluma-
zine metabolites can be presented in the context of MR1 in vitro, the extent to which exogenous
ligands contribute to MAIT cell activation in vivo is unknown. Our data support the hypothesis
that regulation of MAIT cell activation is critically dependent on intracellular infection. Cell-
surface localization of classical Class I molecules is dependent on binding by a peptide that can
be either endogenous or exogenous. This is in contrast to MR1, which we demonstrate is pri-
marily localized to endosomal compartments with features of late endosomes and lysosomes,
consistent with previous findings in mouse embryonic fibroblasts [10]. The difference in intra-
cellular localization between classical Class I molecules and MR1 suggest that translocation to
the cell surface is a key event for MAIT cell recognition of intracellular infection. By
Fig 4. Stx18, VAMP4, and Rab6 silencing alter TGN structure and intracellular MR1 localization. a)
BEAS-2B cells treated with missense, Stx18, Rab6, or VAMP4 siRNA were transfected with pCI:MR1-GFP
for 48 hours, then fixed and imaged. Shown are representative images of the cells used to enumerate
MR1-GFP+ EC. TGN46 staining is shown at 1.5x magnification in greyscale below each image to
demonstrate dispersion or contraction of the TGN. b) MR1-GFP+ EC were identified and quantified as
previously described. On the left, each dot represents the number of MR1-GFP+ EC in a single cell, and the
data shown is representative of 4 independent experiments. On the right, each dot represents the mean
intensity of GFP signal in one individual MR1-GFP+ EC. The data represent all endosomes from the cells
plotted on the left, and are representative of 4 independent experiments. The Mann-Whitney test was used to
determine statistical significance, *p<0.01.
doi:10.1371/journal.ppat.1005524.g004
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maintaining a dynamic endosomal store of MR1, ligands derived from intracellular pathogens
can be rapidly loaded and presented on the cell surface. MR1 that does not encounter intracel-
lular ligand may be rapidly recycled or degraded, keeping access to ligands from normal extra-
cellular gut flora to a minimum. These findings led us to explore the role of endosomal
trafficking in presentation of Mtb ligands on MR1 to MAIT cells.
Fig 5. Mtb-derived ligands are loaded on MR1 using a pathway distinct from that of 6-FP. a) BEAS-2B cells treated with missense, Stx18, Rab6 or
VAMP4 siRNA were transfected with pCI:MR1-GFP for 30 hours, then incubated or not with 6-FP for 18 hours. Cells were then harvested, surface stained
with α-MR1 (26.5) and examined by flow cytometry. Cells were gated on expression of MR1-GFP based on an untransfected control. Shaded histograms
represent the isotype control. Black solid histograms represent the cell surface expression of MR1 after treatment with missense control siRNA, while the
dashed histograms represent the cell surface expression of MR1 in the after treatment with the indicated siRNA. Data is representative of three independent
experiments. b) For Stx18, BEAS-2B cells were transfected with MR1-GFP and incubated for 24 hours, then transfected with Stx18-RFP and incubated for
16 hours. For VAMP4, BEAS-2B cells stably expressing MR1-GFP were transfected with VAMP4-RFP and incubated for 18 hours. Cells co-expressing
MR1-GFP and Stx18 or VAMP4 were imaged live. Images are representative of at least three independent experiments. c) BEAS-2B cells were infected with
Mtb (MOI:8) for 18 hours or incubated with supernatant fromM. smegmatis cultures (Msm Sup). Where indicated, cells were pretreated with 6-FP for 2 hours
prior to infection or addition of supernatant. Cells were then used as APC in an IFNγ ELISPOT assay with IFNγ production by an MR1-restricted T cell clone
as a readout for antigen presentation. Data are representative of two independent experiments, *p<0.01, n.s. not significant.
doi:10.1371/journal.ppat.1005524.g005
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Using lentiviral shRNA knockdown in Mtb-infected APC, we identified a set of trafficking
molecules specifically involved in the presentation of MR1-ligands to MAIT cells. Our results
lead us to postulate a model where, in contrast to classical ER-associated Class I antigen pro-
cessing and presentation, the expression of MR1 in endosomal compartments is critical to reg-
ulation of the processing and presentation of MR1 ligands generated in the context of
intracellular infection with Mtb. In this model, we seek to explain 1) the proteins involved in
generation of MR1+ EC, 2) the location where MR1 interacts with ligand, and 3) the ability of
loaded MR1 to translocate to the cell surface. While we cannot yet say where MR1 is interacting
with Mtb ligand based on our data, we can conclude that MR1 is likely interacting with exoge-
nously added ligands such as 6-FP primarily in a pre-Golgi compartment such as the ER. We
have identified proteins, Stx18, VAMP4, and Rab6, which play a role in maintaining the struc-
ture of the TGN, and ultimately regulate the translocation of MR1 to the cell surface in the con-
text of infection with Mtb (Fig 6). In the context of our model, 6-FP is loaded through a
distinct pathway from those derived in the context of intracellular infection. The ER-associated
Fig 6. Model of MR1 trafficking.Our data support the hypothesis that the primary MR1 presentation pathway for exogenous ligands like 6-FP is through the
ER. MR1 loading of exogenous ligand through this pathway requires the ER-localized SNARE protein, Stx18, but not the TGN-endosome localized trafficking
molecules Rab6 and VAMP4. In contrast, the MR1 presentation pathway for ligands derived from intracellular pathogens like Mtb is primarily through
endosomal compartments, and requires Stx18, Rab6, and VAMP4.
doi:10.1371/journal.ppat.1005524.g006
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SNARE, Stx18, appears to play a role in both of these pathways, whereas the TGN-endosome
localized Rab6 and VAMP4 uniquely contribute to the loading of Mtb ligands. These data sup-
port a role for the MR1+ EC in loading of Mtb ligands.
While we have identified a preliminary framework by which these trafficking proteins par-
ticipate in presentation of Mtb antigens on MR1, there are still many unanswered questions
about howMR1 samples the intracellular environment. At present, there are three ways in
which the immune system is known to sample the endosomal environment, both of which
involve exchange of ligand. The first is through MHC Class II antigen presentation, where pep-
tides derived from the endosomal pathway are exchanged with the invariant chain (Ii) on
MHC Class II molecules in a late endosomal compartment known as the MHC Class II com-
partment (MIIC) (reviewed in [25]). The second is through the MHC Class I endosomal recy-
cling pathway, where MHC Class I molecules are loaded with endosomally-derived peptides
through the action of cathepsins and peptide exchange [26]. The third is through CD1 antigen
presentation, where lipid antigens can be sampled in early and late endosomes, including the
MIIC (reviewed in [27, 28]). Unlike MHC-II, classical MHC-I, and CD1 molecules, neither
self-ligands nor chaperones have been defined for MR1. Although invariant chain (Ii) was pro-
posed as a required chaperone for MR1 [10], we showed that BEAS-2B cells are highly efficient
at presenting antigen to MAIT cells [14] even though they do not express MHC class II or Ii.
Based on this, we hypothesize that there are chaperones in addition to Ii that are able to stabi-
lize MR1 and contribute to endosomal loading of antigen.
Peptide-loaded classical Class I molecules translocate to the cell surface regardless of whether
they contain endogenous or exogenous peptides. CD8+ T cells sample all peptides that are pre-
sented, and the ability of T cells to discriminate self from non-self is determined by the specificity
of the T cell receptor (TCR). Here, constitutive cell surface localization of classical Class I mole-
cules does not lead to indiscriminant T cell activation as thymic selection serves to remove T cells
that are auto-reactive. For MAIT cells, the TCR appears to have broader reactivity from that of
classical CD8+ T cells. Instead, recognition by MAIT cells may be dependent on the regulated
intracellular loading of ligand that in turn leads to cell surface translocation. In support of the
idea that stable expression of MR1 on the cell surface is tightly regulated, we observe that even
the presence of intracellular infection with Mtb or incubation with soluble fractions fromMtb,
there is little to no increase in the level of surface MR1 despite clear activation of MAIT cells.
Similarly, translocation of MR1 to the cell surface in the context of bacterial ligands was not
observed with soluble fractions from E. coli [29], suggesting a common regulatory pathway.
Mtb-derived MR1 ligands have not yet been identified, and we are not able to track the
known small molecule ligands directly in cells. We show clear evidence, however, that traffick-
ing of MR1 in endosomal compartments is key to Mtb antigen presentation, and hypothesize
that the regulation of endosomal trafficking is key to generation of MR1+ EC that can encoun-
ter Mtb ligands and subsequently traffic to the cell surface. Further characterization of targets
identified in this study will provide insight into the novel regulation of loading of ligand on
MR1 and translocation of MR1 to the cell surface in the context of infection. The clear demon-
stration of endosomal trafficking as essential in the MR1-dependent activation of MAIT cells
suggests a different paradigm for howMAIT cell recognition occurs and provides a critical first
step in defining the fundamental mechanisms for MR1 antigen processing and presentation.
Materials and Methods
Bacteria and cells
Mycobacterium tuberculosisH37Rv (ATCC) or H37Rv-expressing dsRED, a kind gift from Joel
Ernst was grown in Middlebrook 7H9 broth supplemented with Middlebrook ADC (Fisher),
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0.05% Tween-80, and 0.5% glycerol. Before infection, bacteria were passaged 15 times through
a tuberculin syringe to obtain a single cell suspension. For culture of colony forming units, bac-
teria were plated on 7H10 agar supplemented with Middlebrook ADC.
The bronchial epithelial cell line BEAS-2B (CRL-9609) was obtained from ATCC and cul-
tured in DMEM + 10% heat inactivated FBS. NHBE cells were obtained from Lonza and were
cultured in BEGM as recommended. CD8+ T cell clones D160 1–23, D466 H4, and D426 B1
have been previously described [3, 30, 31]. Briefly, D160 1–23 is HLA-E restricted, D466 H4 is
HLA-B45 restricted, and D426 B1 is MR1 restricted. T cell clones were expanded as previously
described [32].
Ethics statement
This study was conducted according to the principles expressed in the Declaration of Helsinki.
Study participants, protocols, and consent forms were approved by the Oregon Health & Sci-
ence University Institutional Review Board (IRB00000186). Written informed consent was
obtained from all participants. Uninfected adults were recruited from employees at Oregon
Health & Science University as previously described [33]. Uninfected individuals were defined
as healthy individuals with a negative tuberculin skin test and no known risk factors for infec-
tion with Mtb.
Reagents and antibodies
Enzymes used for molecular cloning were purchased from New England Biolabs. The following
antibodies or reagents were used for fluorescence microscopy and flow cytometry: α-MR1
(26.5, gift from Ted Hansen, biotinylated by Biolegend), α-Class I (W6/32, Serotec), α-TGN46
(Abcam), α-ERGIC-53 (Abcam), goat anti-mouse and anti-rabbit Alexafluor secondary anti-
bodies (Life Technologies), α-β-2-microglobulin (SantaCruz) streptavidin-Alexa647 (Life
Technologies), and CellLights reagents (Life Technologies). 6-formyl pterin was obtained from
Schirck’s Chemical.
Lentiviral shRNA library screen
A subgenomic lentiviral short hairpin RNA (shRNA) library targeting 114 genes trafficking
genes was obtained in collaboration with L. Moita through the RNAi Consortium (Broad Insti-
tute). Genes were represented by at least five independent shRNA constructs arrayed in indi-
vidual wells. The assay design is outlined in S1 Fig. Infection of BEAS-2B cells with lentivirus
was performed as follows. BEAS-2B cells were plated on 96-well tissue culture plates at a con-
centration of 5 x 103 cells per well in 100ul DMEM+10%FBS. After 24 hours the media was
removed and replaced with 10ul virus and 40ul media containing 8ug/ml polybrene and the
plate was centrifuged at 2200 rpm for 90 min at 37°C. After centrifugation, the media was
replaced with 100ul fresh DMEM+10%FBS. The cells were incubated for 48 hours, then
selected with 5ug/ml puromycin for an additional 72 hours before analysis by ELISPOT assay
as follows. Treated cells were infected with H37Rv Mtb (MOI:30) for 18 hours. Following infec-
tion, cells were harvested and divided into four parts, one for counting and three for ELISPOT
assays as described below. To count the relative number of cells per well, samples were fixed,
combined with a fixed number of latex beads, and analyzed by flow cytometry. Wells that con-
tained fewer than 20 cells per 10,000 latex beads were excluded from analysis as APCs from
these wells did not elicit IFNγ response above background. The other three parts were plated as
antigen presenting cells (APC) in IFNγ ELISPOT plates with MR1 (D426B1), HLA-E (D160
1–23), or HLA-B45 (D466H4)-restricted T cells clones. Each well was given a rank order based
on the relative number of cells, which was plotted against the number of IFNγ Spot Forming
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Units (SFU). Each plate of shRNAs was assayed independently three times with each of the
three T cell clones. Prism (GraphPad) was used for data analysis. Each well was given a rank
value based on the relative number of cells and the rank was plotted in ascending order in rela-
tion to the number of spots per well. A linear regression analysis was performed to generate a
best-fit line with 95% confidence intervals. Genes were considered candidates if two of the five
independent shRNA-silenced wells resulted in T cell response that was reduced by at least 25%
compared to the best-fit line in at least two of the three replicates. Selected candidates were
confirmed using gene-specific siRNA as described below.
siRNA knockdown
BEAS-2B cells were plated in 24-, 12-, or 6-well tissue culture plates (Corning), or 1.5mm
glass-bottom chamber slides (Nunc) at 70% confluency and transfected with 50nM siRNA
(Life Technologies) using HiPerfect (Qiagen). After 72 hours, cells were used in assays as indi-
cated below.
RNA isolation, cDNA synthesis, and real-time PCR analysis
Real-time PCR was used to analyze gene expression. Total RNA was isolated from samples
treated with negative control or gene-specific siRNAs using the RNeasy Mini Kit following the
manufacturer’s protocol (Qiagen). cDNA was synthesized from total RNA using the High
Capacity cDNA Reverse Transcription Kit following the manufacturer’s protocol (Life Tech-
nologies). Real time PCR was carried out using TaqMan Universal PCRMaster Mix (Life Tech-
nologies) on a Step One Plus Real-Time PCR System (Applied Biosystems). The FAM-MGB
TaqMan Gene Expression Assays for all targets were obtained from Life Technologies. Reac-
tions were run in triplicate in three independent experiments. Expression data were normalized
to the housekeeping gene GAPDH and relative expression levels were determined using the 2-
ΔΔCT method described by Livak and Schmittgen [34].
Generation and Expression of MR1-GFP
pCI MR1-eGFP was constructed using a cDNA ORF clone for MR1 isoform 1 purchased
through Origene (RG220474, Ref seq: MN_001531.1) utilizing a Mega-primer PCR protocol.
MR1 was first amplified by PCR so that an EcoRI site was integrated into the N-terminal end
of the amplicon and a 25 bp overlap with the sequence for the following eGFP amplicon was
added to the C-terminus (Primers: MR1_FW and MR1_RV). eGFP was then amplified out of a
stock plasmid in our lab with a QGGGGFE flexible linker added to the N-terminus and a KpnI
restriction site added to the C-terminal of the amplicon (Primers: QGGGGFE eGFP_FW and
QGGGGFE eGFP_RV). The gel-purified MR1 and eGFP amplicons were then amplified in a
PCR reaction using the MR1 amplicon as a mega-primer for the reaction. Following PCR puri-
fication (Qiagen cat. 28104) of the MR1 eGFP amplicon, an additional PCR reaction was run
using primers initiating amplification from each terminal end of the template (MR1_FW and
QGGGGFE eGFP_RV). Following gel purification (Qiagen cat. 28704), the 1.8kb MR1 eGFP
insert was cloned into the pCI mammalian expression vector (Promega Cat. E1731) using
EcoRI and KpnI restriction sites. Confirmatory sequencing of our construct revealed a mis-
sense mutation (A116G) within the Origene MR1 sequence that changed the coding for amino
acid 39 from histidine to arginine. This mutation was repaired using mega-primer PCR utiliz-
ing a forward primer that amplified the N-terminal of pCI MR1 eGFP and a 30 bp reverse
primer (MR1 A116wt_ RV) that spanned the region of the mutation and contained the correct
A116 nucleotide. The resulting 145 bp amplicon was then used as a primer along with the
reverse primer (QGGGGFE eGFP_RV) for a subsequent PCR reaction with pCI MR1 eGFP.
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The resulting PCR product was restriction cloned into pCI using EcoRI and KpnI sites. The
completed plasmid was confirmed correct by sequencing through the entire MR1 eGFP insert.
N-terminal Tag-RFP Stx18 and VAMP4 fusion proteins were produced as complete genes
in a production plasmid (Integrated DNA Technologies) containing EcoRI and KpnI restric-
tion sites. The Tag-RFP gene was cut from the production plasmid, gel purified and subcloned
into the pCI mammalian expression vector (Promega Cat. #E1731) using EcoRI and KpnI
restriction sites.
BEAS-2B cells were transfected with the MR1-GFP, Stx18-RFP, or VAMP4-RFP plasmid
constructs using Lipofectamine2000 (Life Technologies) or by nucleofection with Amaxa kit T
(Lonza), program G-016. NHBE cells were transfected with plasmid constructs using the
Amaxa nucleofector, with kit VPI-1005 (Lonza) and programW-001. For experiments with
CellLights, reagent was added one hour after transfection with pCI:MR1-eGFP. Experiments
with VAMP4-RFP co-transfection and Brefeldin A treatment were performed using BEAS-2B
cells that were stably transduced with MR1-GFP lentiviral particles produced by The Univer-
sity of Pennsylvania Vector Core.
ELISPOT assays
BEAS-2B cells in 12- or 6-well tissue culture plates were transfected with siRNAs as indi-
cated above for 72 hours. siRNA transfected cells were infected with Mtb-dsRED (MOI:10
or as indicated) for 18 hours, then harvested, counted, and used in equivalent numbers as
APC (5e3/well) in an IFNγ ELISPOT assay with 1e5 D426 B1, D160 1–23, and D466 H4
CD8+ T cell clones per well as previously described [31]. The data were compared using the
student’s t-test, and all data presented are the average of a minimum of three independent
replicates. For analysis of the functionality of MR1-GFP, BEAS-2B cells were transfected
with MR1-GFP, or mock transfected. After 48 hours, cells were infected for 18 hours, then
harvested, counted and plated at equivalent numbers in an IFNγ ELISPOT assay as
described above. For the ELISPOT experiments with ‘Msm-sup’,M. smegmatis was cultured
with shaking for 24 hours, then pelleted. The supernatant was passaged over a 0.22uM filter,
then used directly in the ELISPOT assay.
CFU assays
Equivalent numbers of cells treated with siRNA and infected with Mtb as indicated above were
lysed and serial dilutions were plated on 7H9 culture plates. Colonies were enumerated after
12–14 days.
MR1 surface stabilization assay
BEAS-2B cells plated in a 12-well tissue culture plate were transfected with siRNAs as indi-
cated above for 72 hours. In the case of VAMP4, the cells were incubated with siRNA for 48
hours. After 72 (48) hours, cells were transfected with pCI:MR1-GFP and incubated for 24
hours. Cells were then incubated at 37°C with 50uM 6-formyl pterin for 16 hours. Cells were
harvested on ice and surface stained with a primary antibody against MR1 (26.5, a kind gift
from Ted Hansen, biotinylated, 1:100) for 40 min on ice in the presence of 2%HuS, 2% goat
serum, and 0.5% FBS. After washing, streptavidin-Alexafluor 647 was added for 40 min on
ice. Cells were washed and fixed, and subsequently analyzed with a BD FACSCanto II flow
cytometer and FACS Diva software (BD). All analyses were performed using FlowJo soft-
ware (TreeStar).
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Fluorescence microscopy
BEAS-2B cells in 1.5mm glass bottom chamber slides (Nunc) were transfected with pCI:
MR1-GFP (2ug/1e6 cells). Transfected cells were infected with H37Rv-dsRED, or treated with
ligands as indicated above. Cells were washed, fixed with 1% paraformaldehyde for 18 hours,
then stained as indicated above with the 26.5 antibody. Images were acquired on a high-resolu-
tion wide-field CoreDV system (Applied Precision) with a Nikon Coolsnap ES2 HQ. Each
image was acquired as z-stacks in a 1–24x1024 format with a 60x 1.42 NA Plan Apo N objec-
tive. Images were deconvolved with an optical transfer function using an iterative algorithm of
10 iterations. Acquired images were analyzed using Imaris (Bitplane). Analysis of MR1-eGFP
EC colocalization with CellLights reagents or antibody staining was performed using the
“Spots” module of Imaris and the “spots colocalization” MatLab Xtension module as described
in S3 Fig.
Data analysis
Data were analyzed and plotted using Prism 5 (GraphPad Software). Statistical significance
was determined using Student’s two-tailed t test, unless otherwise indicated.
Supporting Information
S1 Movie. MR1-GFP localizes to endosomal compartments. BEAS-2B cells were transfected
with pCI:MR1-GFP and incubated for 30 hours. Cells were imaged live every 5 seconds for 10
minutes.
(MOV)
S2 Movie. MR1-GFP localizes to endosomal compartments with late endosome and lyso-
some markers. BEAS-2B cells were transfected with pCI:MR1-GFP and incubated for 30
hours. One hour after transfection, cells were incubated with the lysosome Organelle light
reagent. Cells were imaged live every 5 seconds for 10 minutes.
(MOV)
S1 Fig. shRNA library screen workflow. BEAS-2B cells were seeded in 96-well tissue culture
plates at 5,000 cell per well and incubated for 18 hours. Cells were infected with lentivirus in
the presence of polybrene by spinoculation for 90 minutes at 37°C. The lentiviral library was
arrayed such that each gene in the library was represented by at least 5 unique lentiviral
shRNA constructs in individual wells. Infected cells were incubated for 48 hours, then selected
with 5ug/ml puromycin for an additional 48 hours. Cells were then infected for 18 hours with
Mtb-dsRED (MOI:30). Infected cells were harvested and used as antigen presenting cells
(APC) in an IFNγ ELISPOT assay with MR1-, HLA-E, and HLA-B45 T cell clones in parallel.
A subset of the APC from each well was fixed with 1% PFA, then spiked with latex beads and
analyzed by flow cytometry to determine the relative number of cells harvested from each well.
Prism (GraphPad) was used to plot the number of IFNγ ELISPOTs from each well versus the
relative number of cells per well, and to generate a regression line with a 95% confidence inter-
val. Each shRNA was assayed in triplicate with each of the three T cell clones. The response of
the T cell clones was analyzed and wells were considered hits if the response was at least 25%
below the regression line for at least two of the three replicates. Genes were considered putative
candidates if at least two of the five independent shRNA constructs met the threshold for a hit.
(TIF)
S2 Fig. Impact of gene knock down on trans-Golgi network (TGN) structure. BEAS-2B cells
were treated with missense, Stx18, Rab6, or VAMP4 siRNA for 72 hours. Cells were fixed,
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stained with α-TGN46, and imaged. Shown are representative images from three independent
experiments.
(TIF)
S3 Fig. Quantification of endosomal compartments using Imaris. BEAS-2B cells were trans-
fected with pCI-:MR1-GFP and co-incubated with RFP CellLights reagents for lysosomes
(Lamp1) for 48 hours, then imaged live. The top row displays individual images and a merge of
a representative cell expressing MR1-GFP and Lamp1-RFP. MR1-GFP+ and Lamp1+ EC were
quantified using the “Spots” function on Imaris as shown on the bottom left. Lamp1+ EC co-
localizing with MR1-GFP+ EC were identified using the “Spots colocalization” MatLab Xten-
sion module of Imaris. Quantification of the total number of MR1-GFP+ EC and the number
of MR1-GFP+ Lamp1+ EC for the representative cell is shown in the graph on the bottom right.
This analysis was repeated for each cell imaged and the average number of dual positive endo-
somes for all cells imaged in graphed in Fig 1D.
(TIF)
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